Navigation Links
Lilly Reports Solid First-Quarter Results
Date:4/21/2008

. For the first quarter, Lilly recognized revenue totaling $82.7 million, representing a 16 percent increase compared with the first quarter of 2007.

Animal Health

Worldwide sales of animal health products in the first quarter of 2008 were $235.3 million, an increase of 9 percent compared with the first quarter of 2007. U.S. sales grew 16 percent, to $107.6 million, driven by the acquisition of Ivy Animal Health, Inc. and the launch of Comfortis(TM), a new companion animal product. Sales outside the U.S. grew 4 percent, to $127.7 million, driven primarily by the favorable impact of exchange rates.

2008 Financial Guidance

The company's full-year 2008 earnings guidance is now $3.90 to $4.05 per share. As noted in the table below, the change from earlier guidance results from the tax benefit of $.19 per share resulting from the resolution of the IRS tax audit, a $.09 per share charge related to asset impairments and restructuring (exit costs) primarily related to the termination of the AIR Insulin program, and a $.05 per share charge related to the in-licensing transaction with BioMS Medical. Absent these items, the company's expected 2008 earnings per share would have remained in the range of $3.85 to $4.00. See the table below for further detail. The company's full-year 2008 guidance does not reflect potential charges related to the recently-announced voluntary exit program.

Excluding the effect of the resolution of the IRS tax audit, the estimated effective tax rate has been revised to approximately 22 percent from the previously stated 23 percent. This reduction is the result of a more favorable forecast of the mix of income between the company's domestic and international operations and the alignment of the company's practices with the conclusions of the most recent IRS audit. No other elements of the company's previously issued line item guidance have been changed.

2008 Earnings Per Share Expectations:

---
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
2. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
3. Lilly Announces Termination of AIR Insulin Program
4. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
7. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
8. Lilly Declares Fourth-Quarter Dividend
9. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
10. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
11. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...o,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesCan...ds,adivisionofThompsonsLimitedofBlenheim,Ontario.T...ences,currentseedsbusinessasthecompanyanticipatest...oSciencesHerbicideTolerantTraitTechnologyincornin2.... ,, "Thisacquisitionbringstogethertwostrongpro...
(Date:11/24/2009)... care employment grew by 29,000 jobs in October, ...ent growth during the U.S. recession. However, cli...d health systems are coming closer to having to ac...nistrators. , (Vocus) Nov... growing in October despite the shedding of jobs i...
(Date:11/24/2009)...Newswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX )...mmercializingnovelpainmanagementtherapies,announce...eOfficer,isscheduledtopresentatthe21stAnnualPiperJ...9atTheNewYorkPalaceHotelinNewYork,NewYork. ,, M...,willbeavailabletorespondtoquestionsduringtheprese...
(Date:11/24/2009)... recently approved the Promega PowerPlex 16 HS Sys...nerating DNA records for the National DNA Index Sy...PRWEB) -- The FBI recently approved the Promega P...s participating in, or generating DNA records for,...tly contains more than seven million profiles and ...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
... April 22 Renovis, Inc.,(Nasdaq: RNVS ), today a...dvisory firm, has joined ISS/Risk Metrics in recom...erger agreement with Evotec AG (Frankfurt,Stock Ex...cheduled for May,1, 2008. In the proposed merger, ...ed into the right to receive the equivalent of 1.0...
...il 22 Medarex, Inc.,(Nasdaq: MEDX ) announced to...Stanley Global Healthcare Unplugged Conference at ...vent will be webcast live and will be,available in...site at, http://www.medarex.com . An archived edit...g the event., About Medarex, Medarex is a biopha...
...il 22 Sysmex America, Inc. today,announced the su...ton, OH),beta studies for its integrated hematolog...solution, which combines the Sysmex HST-N hematolo...s, Inc. VARIANT(TM) II TURBO,Link, enables on-dema...setting. "This integrated testing solution, now fu...
Other Biology Technology:Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 2Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 3Medarex to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 2Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 3Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 4
(Date:11/24/2009)... , This release is available in Spanish . ,...re higher levels of inflammatory substances in the...eight; as shown by a research project of the Unive...Soto, a scientist at the School of Pharmacy. , T...mic study in relation to the control of body weigh...
(Date:11/23/2009)... , Washington, D.C. The community-associated str...g bacteria resistant to most common antibioticspos...wn and is making its way into hospitals, according...ectious Diseases . , The new threat is easily p...blic places and has increased the overall burden o...
(Date:11/23/2009)... , TORONTO, November 23, 2009 - The time of day...ording to a new paper produced by a research team ...oronto Scarborough,s vice-principal for research a...s biology at the St. George campus. , Capitali...f the poplar tree, the research team examined how ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Capping a two faced particle gives duke engineers complete control 13514 1Capping a two faced particle gives duke engineers complete control 13514 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 1Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 3Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 4Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 1Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 2
...ailable in German . , Eckhard Boles, co-founde...professor at Goethe-University in Frankfurt, Germa...t cells to ferment xylose into ethanol. Xylose is ...oduction process. The researchers have recently fi...industrial fermentation processes, the yeast Sacc...
...amon Runyon Cancer Research Foundation named 13 ne...ship Award Committee review. The recipients of th...ostdoctoral scientists conducting basic and transl...ding senior investigators across the country. The...the nation,s most promising young investigators to...
...s are exploring extreme conditions for life in a p...ters (66 feet) below the surface of Lake Huron, th...culiar geological formationssinkholes made by wate...harbor bizarre ecosystems where the fish typical o...Instead, brilliant purple mats of cyanobacteriacou...
Other Biology News:Commercial yeasts upgraded with an enzyme for biofuel production 2Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators 2Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators 3Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators 4Great Lake's sinkholes host exotic ecosystems 2
...des the reagents to efficiently differentiate mous...y efficiently promoting myogenic differentiation, ...ogenesis, transcription factor regulation, and in ...therapy. By providing the means to obtain and main...
..., confocal, real-time, single cell kinetic and end... a single, compact unit. The BD Pathway was desig... imaging with sophisticated imaging software to as...ystem allows the user to explore biological events...
...fied procedure and streamlines the bisulfite metho...n the three step reaction that takes place between...onverted into uracil. The EZ DNA Methylation Kits ...nates several precipitation steps and provides res...
... on quantification of the green complex formed bet...phate. The rapid color formation from the reaction...er (600-660 nm) or on a plate reader. The non-radi...d to offer superior sensitivity and prolonged shel...
Biology Products: